Medical Licensing (MD/DO) · Independent exam preparation
Cardiac Surgery Certification (CSC) — Adult Study Guide
Practise adult cardiac surgery decisions: distinguish shock, bleeding and lung injury, interpret hemodynamics, and select safer postoperative nursing interventions.
By CertMedbry · Updated 19 October 2026
Practise distinguishing inadequate preload from pump failure, recognizing tamponade and transfusion complications, troubleshooting temporary pacing, responding to postoperative arrest and neurologic changes, and supporting respiratory recovery. This guide focuses on adult cardiac surgery nursing during the first 48 postoperative hours. Its 60 concepts selectively cover all four domains of the CSC test plan applicable through November 18, 2026; the official outline remains the full examination scope.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
What credential and patient population does this guide address?
This guide addresses CSC (Adult), Cardiac Surgery Certification, a nursing subspecialty credential focused on direct care of acutely or critically ill adults during the first 48 hours after cardiac surgery. RN and APRN applicants take this subspecialty examination; it is not a separate nurse practitioner licensing examination. CMC addresses adult cardiac medicine and is a different credential.
How many questions are there, and how long is the examination?
The August 2026 handbook specifies 90 multiple-choice items in two hours. Seventy-five items are scored, and 15 collect statistical information for future examinations. The examination focuses entirely on adult clinical judgment. The handbook identifies multiple-choice questions; it does not establish additional item formats.
How is the examination delivered, and is it adaptive?
The handbook describes computer-based testing at a PSI testing center or through live remote proctoring. It also describes coordination for paper-and-pencil examinations and testing outside the United States. It specifies a 90-item examination but does not identify computer-adaptive delivery. These learning questions are independent four-option drills and do not simulate an adaptive examination.
Which blueprint applies to this guide?
The August 2026 handbook identifies the plan applicable to examinations taken on or before November 18, 2026: Procedures 11%, Complications 33%, Therapeutic Interventions 43%, and Monitoring and Diagnostics 13%. It is the applicable plan on both October 10 and October 19, 2026. August 2026 identifies the handbook revision.
What changes for examinations on or after November 19, 2026?
AACN launches revised CSC examinations on November 19, 2026. The future plan assigns Procedures 9%, Complications 37%, Therapeutic Interventions 43%, and Monitoring and Diagnostics 11%. This is a revision of the existing nursing subspecialty credential. Candidates testing from that date should use the revised official outline rather than this guide's earlier domain allocation.
Revised CMC and CSC Exams Launch Nov. 19, 2026 · CSC Test Plan — Effective November 19, 2026
What eligibility pathways and jurisdictional requirements apply?
Applicants need a current, unencumbered U.S. RN or APRN license and an eligible nationally accredited adult clinical nursing specialty certification. The two-year option requires 1,750 qualifying direct-care hours, including 875 in the most recent year and 875 in early postoperative adult cardiac surgery care. The five-year option requires 2,000 qualifying hours, including 144 in the most recent year and 1,000 in early postoperative cardiac surgery care. These are eligibility options for the same CSC examination. Qualifying facilities may be U.S.-based, Canada-based, or otherwise meet AACN's stated comparability requirements.
How is passing determined?
The handbook describes criterion-referenced standard setting using the modified Angoff method. Performance is compared with a predetermined standard rather than with other candidates. No numerical passing score is established here. Results on these 20 learning questions do not predict certification success.
How closely do these materials follow the blueprint?
The guide contains 6 Procedures, 20 Complications, 26 Therapeutic Interventions, and 8 Monitoring and Diagnostics concepts. The questions and flashcards each contain 2, 7, 8, and 3 items in those respective domains. These approximate the applicable weights within small collections. Selected teaching includes postoperative tachyarrhythmia decisions, mechanical-support bleeding and thrombosis, drain management, cardiac surgery resuscitation, spinal cord ischemia, post-extubation support, and thrombosis prevention. The official outline remains the full scope; additional study is needed for topics including Maze procedures, stroke, ischemic bowel, psychosocial complications, and broader device-management and prevention protocols.
CSC (Adult) is AACN Certification Corporation's cardiac surgery nursing subspecialty credential for eligible specialty-certified nurses. It is distinct from CMC cardiac medicine certification, advanced practice entry certifications, and physician licensing or surgical board examinations. These independently authored learning materials are not official or endorsed AACN examination items.
Outline used: August 2026 CSC Exam Handbook: test plan applicable through November 18, 2026, and therefore current on October 10, 2026, Asia/Hong_Kong. The workbook label maps to AACN's adult cardiac surgery nursing subspecialty certification. Corrected clinical classification: nursing subspecialty certification; the supplied Medical Licensing (MD/DO) category is preserved solely as historical import metadata. Slug preserved. A revised plan becomes effective November 19, 2026.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Procedures11%
1.What does cardiopulmonary bypass replace during on-pump CABG?
During on-pump coronary artery bypass grafting, the bypass circuit temporarily performs the pumping and gas-exchange functions normally provided by the heart and lungs. This allows the surgeon to construct grafts while the heart may be arrested and protected. The operation reroutes blood around obstructed coronary segments. After separation from bypass, native cardiac performance must again sustain perfusion, so postoperative assessment connects blood pressure with cardiac output, oxygen delivery, temperature, and bleeding.
Apply it
A patient returns after on-pump CABG with an acceptable arterial pressure but cool extremities and declining urine output. Review cardiac output and oxygen-delivery indicators rather than assuming that separation from bypass guarantees adequate tissue perfusion.
Common pitfall: Do not equate bypass support with permanent correction of ventricular dysfunction. The circuit supports circulation during surgery; postoperative myocardial performance still requires direct assessment.
Coronary Artery Bypass Grafting — What to Expect During Surgery · Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values
2.How does off-pump CABG differ from on-pump surgery?
Off-pump CABG constructs coronary bypass grafts while the heart continues beating, without routine use of cardiopulmonary bypass. A stabilizing device limits movement at the operative site. The distinction describes how circulation is supported during graft construction, not whether the operation creates bypass conduits. Both approaches require postoperative surveillance for inadequate perfusion and bleeding. Knowing the actual operative technique prevents attributing every postoperative abnormality to exposure to the bypass circuit.
Apply it
The handoff states that CABG was completed on a beating heart without extracorporeal circulation. Record this as off-pump surgery, then evaluate new hypotension using current perfusion and bleeding findings rather than an assumed bypass-related mechanism.
Common pitfall: Off-pump does not mean percutaneous coronary intervention or absence of surgical grafts. It also does not eliminate the possibility of postoperative hemodynamic instability.
Coronary Artery Bypass Grafting — What to Expect During Surgery
3.Why does the distinction between valve repair and replacement matter?
Valve repair reconstructs the patient's valve; replacement inserts a mechanical or bioprosthetic prosthesis. Mechanical valves require long-term vitamin K antagonist anticoagulation, usually warfarin. Direct oral anticoagulants are contraindicated for mechanical prostheses. The 2020 ACC/AHA guideline specifies a target INR of 3.0 for mechanical mitral replacement. Bioprosthetic replacement does not itself impose the same lifelong VKA requirement; treatment depends on valve position, postoperative timing, and other anticoagulation indications. Initial anticoagulation after implantation and interruption of established anticoagulation for a later procedure are distinct clinical settings.
Apply it
After new mechanical valve implantation, the 2024 EACTS/EACTAIC blood-management guidance supports starting VKA therapy with UFH or LMWH bridging when surgical hemostasis permits, continuing bridging until the therapeutic INR is achieved. Assess drain output, ongoing bleeding, and thrombotic risk before initiation. For a patient taking long-term warfarin who later needs elective procedural interruption, the 2022 CHEST guideline suggests against heparin bridging, including for mechanical valves. This elective-interruption recommendation does not describe initial anticoagulation immediately after implantation.
Common pitfall: Do not teach that every mechanical mitral valve requires bridging whenever warfarin is interrupted. The 2020 ACC/AHA guidance supports bridging in selected mechanical-valve patients, including mechanical mitral replacement, whereas CHEST suggests against bridging for elective interruption. Identify the guideline and clinical setting, then weigh valve-related thrombotic risk against procedural bleeding risk. A long-term INR target does not authorize immediate anticoagulation during uncontrolled postoperative hemorrhage.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 3 - American College of Cardiology · 2024%20EACTS%20Guideline%20on%20Patient%20Blood%20Management.pdf · Perioperative Management of Antithrombotic Therapy | Pulmonary Vascular - American College of Chest Physicians
4.Which factors distinguish selection of transcatheter from surgical aortic valve replacement?
For severe aortic stenosis when a bioprosthesis is appropriate, the 2020 ACC/AHA framework weighs symptoms, age, life expectancy, surgical risk, and transfemoral access feasibility. It favors surgical replacement below age 65 or with life expectancy above 20 years, and feasible transfemoral TAVR above age 80 or with life expectancy below 10 years. For symptomatic patients aged 65–80 suitable for either approach, shared decision-making selects the procedure. Unsuitable vascular access can favor surgery despite older age. These are procedural selection criteria, not interchangeable postoperative pathways. [ACC/AHA valve guidance](https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2020/12/16/21/58/2020-ACC-AHA-VHD-GL-Pt-1-GL-VHD).
Apply it
An 82-year-old with symptomatic severe aortic stenosis is being assessed for replacement. Age supports considering transfemoral TAVR, but unsuitable access anatomy changes the procedural discussion; age alone does not establish feasibility.
Common pitfall: Do not assume every older patient is suitable for transfemoral TAVR. Access anatomy, expected survival, quality of life, and surgical risk remain decisive.
5.How does a pericardial window relieve fluid-related cardiac compression?
A pericardial window creates an opening that permits pericardial fluid to drain, reducing the possibility of recurrent accumulation in a confined sac. Its purpose differs from removing pleural fluid alone. Hemodynamic benefit depends on relieving actual compression, not simply documenting that fluid exists. In postoperative patients, blood may be loculated, and the drainage approach must account for its position and character. Persistent instability after drainage requires reassessment for residual compression or another cause.
Apply it
A patient with recurrent symptomatic pericardial accumulation is scheduled for a window. Explain that the procedure creates a drainage route, then compare perfusion and imaging before and after intervention to determine whether cardiac filling improves.
Common pitfall: Do not assume that any pleural drain adequately drains the pericardium. The spaces and drain positions differ, and postoperative collections may be localized.
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
6.Why does thoracic aortic repair require careful bleeding and temperature assessment?
The CSC outline includes both endovascular and open thoracic aortic repair. These procedures should not be treated as interchangeable exposures when evaluating postoperative blood loss. Extensive open surgery, cardiopulmonary bypass when used, and hypothermia can contribute to impaired hemostasis, while a focal surgical source may coexist. The useful decision is to integrate the operative report, drainage, temperature, platelet and coagulation results, and perfusion rather than assigning all bleeding to one mechanism.
Apply it
Following open thoracic aortic repair, a patient has ongoing drainage, hypothermia, and abnormal coagulation results. Recognize a possible systemic contribution while maintaining urgent surgical assessment, because correction of laboratory abnormalities alone may not stop focal bleeding.
Common pitfall: The procedure name alone cannot establish the bleeding mechanism. Aortic surgery may produce simultaneous surgical and systemic hemostatic problems requiring parallel assessment.
CSC Exam Handbook — August 2026 · 2024 EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery
Complications33%
7.How do low cardiac output and low vascular resistance produce different shock patterns?
Arterial pressure reflects the interaction of blood flow and vascular resistance. A low cardiac index with impaired perfusion suggests inadequate pump output, whereas hypotension with preserved or elevated output and low systemic vascular resistance suggests a predominantly vasodilatory problem. These patterns can coexist after cardiac surgery. Combine pressure-flow measurements with serial capillary refill, skin temperature, mental status, urine output, and lactate trends. ESICM recommends echocardiography as the first-line imaging assessment to identify the shock mechanism and serial reassessment when the response is inadequate.
Apply it
One patient has hypotension with a cardiac index of 1.7 L/min/m²; another has the same pressure with an index of 3.4 and low resistance. Their similar arterial pressures do not justify identical circulatory treatment. Compare echocardiographic findings and perfusion responses as treatment proceeds.
Common pitfall: Raising blood pressure is not synonymous with restoring flow. Excessive vasoconstriction can increase ventricular workload when inadequate cardiac output is the principal problem.
Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values · Visual-abstract-final.pdf
8.How can hypovolemia be distinguished from congestive low-output physiology?
Both inadequate circulating volume and ventricular dysfunction can reduce cardiac output. Recent volume loss and low filling pressures support inadequate preload; elevated pressures with low output raise concern for congestion, ventricular dysfunction, or obstructed filling. Filling pressure does not directly measure ventricular volume or predict fluid responsiveness. ESICM supports dynamic assessment, such as a passive-leg-raise response measured by stroke volume or cardiac output when feasible, alongside echocardiography and congestion assessment. Additional fluid requires both a plausible flow benefit and acceptable risk of pulmonary or venous congestion; no fixed CVP target establishes successful resuscitation.
Apply it
Two patients have oliguria and low output. One has blood loss and a reproducible stroke-volume increase with a reversible preload maneuver. The other has elevated pressures, pulmonary congestion, and no flow increase. The second pattern argues against repeating fluid solely to treat oliguria.
Common pitfall: Oliguria alone does not prove fluid depletion. Fluid responsiveness also does not automatically mean fluid is needed: weigh perfusion benefit against congestion and respiratory harm.
Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values · KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury · Visual-abstract-final.pdf
9.Which findings suggest postoperative cardiac tamponade?
Tamponade occurs when pericardial pressure impairs cardiac filling and reduces output. Following cardiac surgery, a localized blood collection can compress selected chambers, so classic findings and uniform pressure equalization may be absent. Worsening hypotension, increasing venous pressure, declining output, and unexpectedly reduced drainage are concerning when considered together. Echocardiography evaluates the collection and its hemodynamic effects. Unstable postoperative tamponade requires urgent drainage planning rather than treatment of the pressure reading alone.
Apply it
Mediastinal drainage abruptly falls while arterial pressure decreases, venous pressure rises, and peripheral perfusion worsens. Escalate concern for retained blood and cardiac compression, arranging urgent surgical and echocardiographic assessment rather than celebrating the lower drain output.
Common pitfall: Low drain output can reflect obstruction rather than hemostasis. Absence of a complete classic tamponade triad does not exclude localized postoperative compression.
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
10.How does surgical bleeding differ from diffuse coagulopathic bleeding?
A focal operative source and impaired systemic hemostasis are different mechanisms that can occur together. Persistent bleeding despite relatively preserved coagulation findings increases concern for a surgical source; diffuse bleeding with platelet, fibrinogen, or coagulation abnormalities supports a systemic contribution. Laboratory and viscoelastic testing help characterize correctable deficits but cannot exclude a disrupted surgical vessel. The central decision is whether hemostatic treatment, surgical reassessment, or both are needed without allowing one pathway to delay the other.
Apply it
A patient continues losing blood despite correction of documented coagulation abnormalities. Drainage remains brisk and perfusion deteriorates. Reassess for an operative source rather than repeatedly giving additional products without a new explanation for their use.
Common pitfall: Abnormal coagulation tests do not prove that all bleeding is medical. Conversely, visible drainage does not identify which blood component, if any, is deficient.
2024 EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery
11.Why can postoperative anemia impair oxygen delivery despite normal saturation?
Arterial oxygen content depends mainly on hemoglobin concentration and hemoglobin oxygen saturation. A pulse oximeter reports saturation, not the amount of oxygen carried per unit of blood. Consequently, marked anemia can reduce oxygen delivery despite an apparently reassuring saturation. Delivery also depends on cardiac output. Transfusion decisions should therefore integrate bleeding, hemodynamic stability, ischemic concerns, and hemoglobin rather than treating either saturation or a single laboratory value as a complete assessment.
Apply it
An anemic postoperative patient has an SpO2 of 99% but falling cardiac output and worsening perfusion. Recognize that fully saturated remaining hemoglobin may still carry insufficient oxygen, and assess the combined delivery problem.
Common pitfall: Supplemental oxygen cannot restore missing hemoglobin mass. A normal saturation should not be used to dismiss clinically important anemia or inadequate cardiac output.
Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values · Red Blood Cell Transfusion: 2023 AABB International Guidelines
12.How does right ventricular failure alter interpretation of filling pressures?
The right ventricle must move systemic venous return through the pulmonary circulation before the left heart can receive it. Right ventricular dysfunction can therefore produce elevated right-sided pressure together with inadequate forward flow. A high CVP does not establish adequate left ventricular preload or systemic perfusion. Compare pressure trends, cardiac output, pulmonary pressures, and echocardiographic right ventricular size and function. ESICM supports serial echocardiography and assessment of venous and pulmonary congestion when judging further fluid. A rising CVP without improved flow is a warning against treating pressure alone as evidence of successful resuscitation.
Apply it
After surgery, CVP rises while output falls. Echocardiography shows right ventricular dilation and poor contraction. Reassess pulmonary loading and ventricular function; further fluid requires evidence of benefit and assessment of congestion rather than an assumption that all low output reflects volume depletion.
Common pitfall: Pressure upstream from a failing ventricle can rise while forward flow falls. Neither reflex fluid administration nor reflex volume removal follows from CVP alone.
Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values · Visual-abstract-final.pdf
13.Which post-TAVR conduction changes require extended surveillance or pacing support?
Under the ACC pathway, new first- or second-degree AV block, new bundle-branch block, progression of baseline first- or second-degree AV block, or QRS prolongation of at least 10% precludes the uncomplicated early-discharge pathway. Continue telemetry until conduction is stable for at least 48 hours, then discharge with outpatient monitoring for at least 14 days. New or progressive conduction disease also warrants consideration of electrophysiology study and permanent pacing. Persistent complete heart block requires a secure temporary pacing lead before leaving the procedure room.
Apply it
A patient develops new left bundle-branch block and PR prolongation after TAVR. Continue telemetry until conduction has remained stable for at least 48 hours and arrange outpatient monitoring for at least 14 days. If persistent complete heart block develops, secure temporary pacing immediately while the heart team evaluates definitive treatment.
Common pitfall: Surveillance criteria do not make every new bundle-branch block an automatic permanent-pacemaker indication. Distinguish monitored observation, secure temporary pacing for persistent complete block, and individualized permanent-pacing evaluation. Normal blood pressure does not establish conduction stability.
ACC Decision Pathway on Conduction Disturbances in TAVR: Key Points
14.Which findings support TRALI, and how do CDC surveillance criteria distinguish it from TACO?
CDC TRALI surveillance criteria require no acute lung injury before transfusion; onset during or within six hours after transfusion cessation; hypoxemia, such as PaO2/FiO2 ≤300 or oxygen saturation below 90% on room air; bilateral infiltrates on chest radiography; and no evidence of left atrial hypertension. Assess competing acute lung injury risks when assigning the transfusion relationship. TRALI produces permeability-related pulmonary edema. TACO requires at least three qualifying findings within 12 hours after transfusion cessation, including respiratory distress, pulmonary edema, or both. Other categories are otherwise unexplained cardiovascular changes, fluid overload, and elevated BNP or NT-proBNP.
Apply it
New bilateral infiltrates and a PaO2/FiO2 ratio of 180 two hours after transfusion, without preceding lung injury or left atrial hypertension, support TRALI evaluation. Respiratory distress, pulmonary edema, and fluid overload supply three TACO categories. Elevated BNP or NT-proBNP is supportive; the January 2026 CDC protocol specifies no required baseline ratio or age-adjusted numerical threshold. Missing paired biomarker measurements do not prevent classification when other criteria are met.
Common pitfall: Respiratory distress and pulmonary edema are separate TACO categories; several manifestations within one category do not create additional categories. Timing alone establishes neither diagnosis. Stop a suspected causative transfusion, support oxygenation, and initiate reaction evaluation while assessing overlapping or alternative causes.
15.How does hemodynamic stability determine treatment of postoperative rapid atrial fibrillation or flutter?
Rapid atrial fibrillation or flutter can impair filling and output while increasing myocardial oxygen demand. When instability is attributable to the rhythm, immediate synchronized electrical cardioversion is indicated. Stable patients permit pharmacologic rate or rhythm control. Without preexcitation, an IV beta-blocker or nondihydropyridine calcium-channel blocker can slow ventricular response, but these agents can worsen decompensated systolic heart failure. IV amiodarone can be useful for rate control in selected critically ill patients without preexcitation. [AHA adult advanced life support guidance](https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines/adult-advanced-life-support).
Apply it
New rapid atrial fibrillation accompanies hypotension and altered mentation. Establish whether the rhythm is driving deterioration and prepare immediate synchronized cardioversion. A stable patient allows ECG assessment and selection of medication according to ventricular function and pressure.
Common pitfall: Treat the cause of deterioration as well as the rate. Preexcited atrial fibrillation requires a different pathway: AV nodal blockers and IV amiodarone can precipitate ventricular fibrillation. Consider arrhythmia duration and thromboembolic risk when planning nonemergency conversion.
16.Why does ARDS require attention to ventilator-induced injury?
ARDS creates an injured lung in which the volume available for safe ventilation is reduced and unevenly distributed. Delivering large tidal volumes can overdistend the remaining aerated regions and amplify injury. The primary ventilation guideline recommends limiting tidal volume according to predicted body weight and limiting plateau pressure. A postoperative oxygenation problem therefore requires assessment of both its cause and the mechanical stress imposed by ventilation, rather than escalating inspired oxygen while ignoring delivered volume and pressure.
Apply it
A patient with postoperative ARDS has worsening oxygenation while receiving a large tidal volume based on actual body weight. Recalculate the protective volume using predicted body weight and evaluate plateau pressure alongside oxygenation support.
Common pitfall: A higher oxygen saturation does not prove that ventilation is lung protective. Excessive tidal volume or inspiratory pressure can cause harm despite improved oxygenation.
ATS/ESICM/SCCM Mechanical Ventilation in Adult Patients With ARDS — 2017
17.How can a severe protamine reaction present?
Protamine can cause severe hypotension, cardiovascular collapse, anaphylactic or anaphylactoid reactions, and pulmonary vasoconstriction with pulmonary hypertension. A sudden change occurring during administration is a critical temporal clue. The prescribing information identifies prior protamine exposure and exposure through protamine-containing insulin among relevant risk considerations. Assessment must distinguish the reaction from bleeding or unrelated pump failure while promptly stopping administration and providing emergency support; the reaction is not simply evidence of inadequate heparin reversal.
Apply it
During protamine administration, a patient's arterial pressure falls abruptly and pulmonary artery pressure rises. Stop the infusion and activate emergency evaluation for a protamine reaction while supporting circulation and assessing competing postoperative causes.
Common pitfall: Do not give additional protamine merely because instability follows its administration. Excess dosing and severe drug reactions require different reasoning from residual heparin effect.
18.How is the 4Ts score calculated and applied to postoperative suspected HIT?
The ASH clinical pocket guide assigns 0–2 points to each of four components. Thrombocytopenia: 2 for a platelet fall greater than 50% with nadir ≥20 × 10^9/L; 1 for a fall of 30–50% or nadir 10–19 × 10^9/L; 0 for a fall below 30% or nadir below 10 × 10^9/L. Timing: 2 for clear onset on days 5–14 or a fall within one day with heparin exposure during the preceding 30 days; 1 for compatible but unclear days 5–14 timing, onset after day 14, or a fall within one day with exposure 30–100 days earlier; 0 for a fall within four days without recent exposure. Thrombosis or other sequelae: 2 for confirmed new thrombosis, injection-site skin necrosis, an anaphylactoid reaction after an IV heparin bolus, or adrenal hemorrhage; 1 for progressive or recurrent thrombosis, suspected but unconfirmed thrombosis, or non-necrotizing erythematous skin lesions; 0 for none. Other causes: 2 when none are apparent, 1 when another cause is possible, and 0 when another cause is definite. Totals of 0–3 indicate low probability, 4–5 intermediate probability, and 6–8 high probability.
Apply it
Heparin exposure begins during bypass on day 0. After an early postoperative platelet decline and recovery to 240 × 10^9/L, a second decline begins on day 7, reaching 100 × 10^9/L. The fall is approximately 58%, with nadir above 20: 2 points. Clear day-7 onset earns 2 points. No thrombosis or characteristic sequelae earns 0. A possible infection provides a competing explanation: 1 point. Total 5 indicates intermediate probability. If a new DVT is confirmed, the total becomes 7, indicating high probability. Contrast an immediate day-2 decline without heparin exposure in the preceding 100 days: timing earns 0, and a definite bypass-related explanation earns 0 for other causes.
Common pitfall: The 4Ts estimates pretest probability; it does not confirm HIT. A platelet count can remain within the reference range despite a clinically important relative fall. Conversely, an early postoperative decrease alone does not establish immune HIT. Verify prior heparin exposures, examine the entire platelet trajectory, and reassess competing causes. ASH generally recommends against HIT testing with a reliable low score; intermediate or high scores warrant immunoassay testing and initial management according to bleeding risk and clinical probability.
Choosing Wisely — American Society of Hematology · ASH Diagnosis and Management of Heparin-Induced Thrombocytopenia · watermark-ash_vte_hit_pocketguide.pdf
19.How do HIT immunoassays and functional assays answer different questions?
A HIT immunoassay detects antibodies directed against relevant platelet factor 4–heparin complexes, while a functional assay evaluates whether antibodies activate platelets. An antibody result therefore does not automatically establish clinically important platelet activation. ASH integrates testing with the 4Ts pretest probability and immunoassay strength. Functional testing is often useful after a positive immunoassay, although selected patients with high clinical probability and a strongly positive immunoassay may not require it for decision-making.
Apply it
A postoperative patient has an isolated positive PF4 immunoassay but a low-probability clinical pattern. Reassess the pretest probability and discuss appropriate confirmatory interpretation instead of treating the antibody result as equivalent to proven platelet-activating HIT.
Common pitfall: Do not interchange antibody detection with functional confirmation. Equally, do not delay treatment in a strongly suspicious case while waiting for every test result.
ASH Diagnosis and Management of Heparin-Induced Thrombocytopenia
20.Which creatinine and urine-output changes meet established AKI criteria?
KDIGO defines AKI by any of three findings: serum creatinine increasing at least 0.3 mg/dL within 48 hours; creatinine reaching at least 1.5 times baseline within seven days; or urine output below 0.5 mL/kg/hour for six hours. Either a qualifying creatinine change or urine-output pattern can establish AKI. A value still inside the laboratory reference interval does not exclude injury when the change from baseline meets a criterion.
Apply it
Creatinine rises from 0.8 to 1.2 mg/dL within 24 hours after surgery. The 0.4 mg/dL increase meets the creatinine definition of AKI even if the final value appears relatively modest on the laboratory report.
Common pitfall: Do not wait for a dramatic absolute creatinine value. Compare with baseline, calculate the change, and assess the duration of reduced urine output.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
21.How is AKI severity staged when creatinine and urine output disagree?
Use the highest adult KDIGO stage met by either creatinine or urine output after establishing AKI. Table 2 criteria are: | Stage | Serum creatinine or kidney replacement criterion | Urine output | | --- | --- | --- | | 1 | 1.5–1.9 times baseline, or increase ≥0.3 mg/dL | <0.5 mL/kg/hour for 6 to <12 hours | | 2 | 2.0–2.9 times baseline | <0.5 mL/kg/hour for ≥12 hours | | 3 | ≥3 times baseline, increase to ≥4.0 mg/dL, or initiation of kidney replacement therapy | <0.3 mL/kg/hour for ≥24 hours, or anuria for ≥12 hours | The diagnostic timing remains a creatinine rise ≥0.3 mg/dL within 48 hours or ≥1.5 times baseline within seven days. A less severe creatinine result does not override a higher qualifying urine-output stage.
Apply it
A 70-kg patient produces 25 mL/hour for 13 hours, while creatinine has risen only slightly. Output is approximately 0.36 mL/kg/hour, meeting the stage 2 urine-output criterion despite a less severe creatinine classification.
Common pitfall: Do not average away a sustained qualifying oliguria interval or assign severity solely from creatinine. Confirm measurement accuracy, then apply the highest valid stage.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
22.How does CAM-ICU distinguish hypoactive delirium from insufficient arousal for assessment?
Begin with the Richmond Agitation-Sedation Scale (RASS). At RASS −4 or −5, document CAM-ICU as unable to assess because arousal is insufficient; this is not a negative delirium assessment. At RASS −3 or higher, proceed through CAM-ICU: establish an acute change or fluctuating course, test attention, evaluate consciousness, and assess disorganized thinking when required. For the auditory attention test, ask the patient to squeeze on each A in SAVEAHAART; missed A responses and squeezes on other letters count as errors. More than two errors indicates inattention. CAM-ICU is positive when acute change/fluctuation and inattention coexist with either altered consciousness, indicated by RASS other than zero, or disorganized thinking. Reduced arousal alone does not establish delirium.
Apply it
A previously attentive postoperative patient is now withdrawn, maintains eye contact to voice for 15 seconds, and makes four attention-test errors. This is RASS −1 with acute change, inattention, and altered consciousness: CAM-ICU positive, consistent with hypoactive delirium despite correctly answering reasoning questions. Conversely, a deeply sedated patient who responds only to physical stimulation has RASS −4 and cannot undergo an interpretable CAM-ICU assessment. Record unable to assess, review sedation, and repeat when arousal permits.
Common pitfall: Quiet behavior does not exclude delirium, and unable to assess does not mean delirium absent. A positive screen identifies a syndrome requiring evaluation of contributors such as medication exposure, pain, sleep disruption, hypoxemia, infection, or metabolic disturbance.
23.How are bleeding and thrombosis balanced during VAD or ECMO support?
VAD and ECMO circuits expose blood to artificial surfaces, promoting coagulation disturbances with simultaneous bleeding and thrombosis risks. Anticoagulation depends on the device, surgical hemostasis, and patient physiology. During postcardiotomy extracorporeal support, delaying UFH until satisfactory hemostasis may be appropriate; use serial aPTT and/or anti-Xa measurements plus clinical and circuit assessment.
Apply it
New bleeding during support requires urgent assessment of surgical causes, coagulation deficits, and anticoagulant effect. The support team may reduce anticoagulation while monitoring circuit pressure, flow, and thrombosis.
Common pitfall: Bleeding does not eliminate circuit thrombosis risk. No single coagulation test predicts both complications.
2024%20EACTS%20Guideline%20on%20Patient%20Blood%20Management.pdf
24.Why can postoperative glucose management cause harm at both extremes?
Critical illness can produce hyperglycemia, but aggressive insulin treatment can cause hypoglycemia and harmful variability. The SCCM guideline favors avoiding intensive adult glucose targets and using protocols that minimize hypoglycemia. Risk rises when nutrition changes, insulin sensitivity changes, or monitoring does not keep pace with an intravenous infusion. A glucose result must therefore be interpreted with the insulin trend and current nutritional delivery rather than treated as an isolated value.
Apply it
Enteral nutrition is interrupted while an intravenous insulin infusion continues unchanged. Recognize the increased hypoglycemia risk, follow the interruption protocol, and increase surveillance rather than waiting for the next routine glucose measurement.
Common pitfall: A previously stable infusion rate may become unsafe when nutrition stops. Tight numerical control is not beneficial if achieved through recurrent hypoglycemia.
SCCM Guidelines on Glycemic Control for Critically Ill Children and Adults — 2024
25.How can analgesic-related respiratory depression resemble uncomplicated sedation?
Analgesia and sedation require separate assessment because reduced distress does not necessarily mean safe ventilation. A patient receiving an opioid may become less responsive while respiratory effort falls and carbon dioxide accumulates. PADIS supports assessment-driven pain management and regular sedation assessment. Evaluate arousal, respiratory pattern, and ventilation alongside pain relief. Supplemental oxygen can preserve saturation during hypoventilation, so an acceptable saturation should not end the assessment of a newly somnolent patient.
Apply it
After repeated analgesic doses, a patient becomes difficult to arouse and breathes slowly while receiving oxygen. Assess ventilation and medication effects promptly rather than interpreting the reduced movement and preserved saturation as successful pain control.
Common pitfall: Sedation is not a pain score, and oxygen saturation is not a direct measure of ventilation. Reassess both analgesic benefit and respiratory consequences.
SCCM 2018 PADIS Guidelines · OpenStax Fundamentals of Nursing — Acid-Base Balances
26.Which new lower-limb findings after aortic repair suggest spinal cord ischemia?
New bilateral leg weakness or paralysis after open or endovascular thoracoabdominal aortic repair requires immediate assessment for spinal cord ischemia, especially following hypotension. Compare motor function with the documented postoperative baseline. The ACC/AHA aortic guideline recommends prompt optimization of spinal cord perfusion and reduction of intrathecal pressure for delayed dysfunction. Its rescue measures include raising MAP above 100 mm Hg, restoring volume and oxygen-carrying capacity, correcting tachyarrhythmias, and cerebrospinal fluid drainage when indicated. These are directed rescue measures for suspected cord injury. [ACC/AHA aortic guideline slides](https://professional.heart.org/en/-/media/PHD-Files-2/Science-News/2/2022/2022-Aortic-Disease-Guideline-Slide-Set.pdf).
Apply it
A previously mobile patient develops bilateral leg weakness after a hypotensive episode following aortic repair. Activate immediate surgical and neurologic assessment, support the prescribed perfusion target, and prepare for expert lumbar-drain assessment rather than waiting for sedation to wear off.
Common pitfall: An initially normal motor examination does not exclude delayed injury. Lumbar drainage requires controlled pressure and volume limits; unrestricted drainage is unsafe.
Therapeutic Interventions43%
27.How should a fluid intervention be judged after cardiac surgery?
A fluid intervention aims to improve forward flow when additional preload is likely to help. ESICM supports dynamic responsiveness assessment and weighing expected benefit against pulmonary and venous congestion. Measure stroke volume or cardiac output before and after the intervention, then reassess capillary refill, skin perfusion, urine-output trends, and respiratory status. A CVP increase without improved flow is not a successful response, and a fixed CVP target should not drive repeated boluses. Echocardiography helps identify ventricular dysfunction or obstruction when the expected benefit is absent.
Apply it
After an assessed fluid challenge, CVP rises but output and peripheral perfusion do not improve, while oxygenation worsens. Stop repeating the same intervention and reassess ventricular function, obstruction, and congestion.
Common pitfall: Fluid responsiveness predicts a possible flow increase; it does not establish that the benefit outweighs harm. Judge both perfusion response and tolerance.
Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values · KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury · Visual-abstract-final.pdf
28.When does a vasopressor address the main hemodynamic deficit?
Hypotension with preserved flow and low systemic resistance supports treatment of inadequate vascular tone after volume assessment. Norepinephrine increases vascular tone and pressure but also ventricular afterload; monitor output and tissue perfusion as well as MAP. The [EACTS/EACTAIC/EBCP bypass guideline](https://www.biomedsimulation.com/wp-content/uploads/2025/02/2024-EACTS-EACTAIC-EBCP-CPB-Guidelines.pdf) discusses perioperative vasoactive support and its loading effects. ESICM supports individualized pressure targets and serial perfusion assessment.
Apply it
With low resistance and preserved output, prescribed vasopressor support addresses a plausible deficit. If pressure rises while output and perfusion worsen, reassess the response.
Common pitfall: A pressure response alone does not establish restored organ perfusion.
Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values · Visual-abstract-final.pdf
29.When is augmenting contractility more relevant than adding preload?
Low output with impaired ventricular contraction despite adequate filling supports considering inotropic treatment after excluding obstruction and rhythm causes. Dobutamine or milrinone can support postoperative low-output physiology; monitor pressure, rhythm, output, and perfusion. The [EACTS/EACTAIC/EBCP guideline](https://www.biomedsimulation.com/wp-content/uploads/2025/02/2024-EACTS-EACTAIC-EBCP-CPB-Guidelines.pdf) describes these agents and cautions about arrhythmias and increased myocardial oxygen demand.
Apply it
Low index, congestion, poor contraction on echocardiography, and no useful fluid response favor pump support over another bolus.
Common pitfall: Tachycardia alone is not a beneficial output response. Repeat echocardiographic and perfusion assessment when treatment fails.
Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values · 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis · Visual-abstract-final.pdf
30.When are diuretics useful in a patient with AKI?
KDIGO advises against using diuretics to prevent AKI or to treat the kidney injury itself, except for managing volume overload. A diuretic can increase urine output without demonstrating recovery of filtration or improving the underlying injury. The treatment goal must therefore be explicit: relieving excess volume rather than converting a urine-output number into a presumed renal cure. Continue assessing creatinine, electrolytes, perfusion, fluid balance, and the need for other support.
Apply it
A patient with AKI has pulmonary congestion and a positive fluid balance. A prescribed diuretic may address overload, but a subsequent increase in urine volume should not be documented as proof that kidney injury has resolved.
Common pitfall: Do not use diuretic-induced urine output as evidence that AKI was prevented or cured. Volume management and recovery of kidney function are different outcomes.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
31.How is loss of temporary pacemaker capture recognized and addressed?
Capture occurs when a pacing stimulus depolarizes the intended chamber. A pacing spike without the expected subsequent atrial or ventricular depolarization indicates failure to capture, provided the tracing is correctly interpreted. Output is adjusted in milliamperes, and connections and lead integrity must also be assessed. In a dependent or unstable patient, establish effective backup support immediately while troubleshooting. Electrical capture should be followed by evidence of mechanical perfusion rather than judged from pacing spikes alone.
Apply it
Ventricular pacing spikes continue, but several are not followed by QRS complexes and pressure falls. Activate immediate support, inspect the pacing system, and increase prescribed output as appropriate while confirming restored QRS complexes and a perfusing pulse.
Common pitfall: Increasing sensitivity does not directly correct an inadequate pacing stimulus. Output controls stimulus strength; sensitivity determines which intrinsic electrical signals the generator detects.
32.How does the sensitivity setting affect temporary pacemaker sensing?
Sensitivity determines the minimum electrical signal the pacemaker recognizes, expressed in millivolts. A lower numerical setting makes the device more sensitive; a higher setting makes it less sensitive. Undersensing can allow pacing despite intrinsic beats, while oversensing can inhibit needed pacing by treating noise or unrelated signals as cardiac activity. Interpret the ECG and device behavior together, then adjust the appropriate setting and inspect the system rather than changing output indiscriminately.
Apply it
Intrinsic ventricular complexes are present, but the temporary generator continues delivering inappropriately timed stimuli. Suspect undersensing, review lead connections and signal amplitude, and consider a lower millivolt setting under the prescribed troubleshooting process.
Common pitfall: The numerical direction is counterintuitive: decreasing millivolts increases sensitivity. Excessive sensitivity can create oversensing and inappropriate pacing inhibition, so reassessment remains essential.
33.How does immediate resuscitation differ after cardiac surgery?
The 2025 AHA guidance supports immediate three stacked shocks for witnessed VF arrest after cardiac surgery when a trained professional is present, with CPR if unsuccessful within one minute. For witnessed asystole or bradycardic arrest with temporary epicardial wires already present, attempt immediate pacing and begin CPR within one minute if unsuccessful. Activate the surgical arrest team simultaneously. Rapid resternotomy is reasonable early after surgery in an appropriately staffed, equipped ICU; external compressions provide perfusion when emergency reopening is not immediately available. [AHA cardiac surgery resuscitation guidance](https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines/adult-and-pediatric-special-circumstances-of-resuscitation).
Apply it
A monitored patient develops witnessed VF two hours after surgery. A trained team delivers immediate stacked shocks while activating surgical support; unsuccessful defibrillation must not postpone CPR beyond one minute.
Common pitfall: The brief rhythm-specific sequence is not permission for prolonged absence of perfusion. Suspected tamponade or hemorrhage also requires rapid surgical correction.
CSC Exam Handbook — August 2026 · 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
34.How do IABP timing and aortic valve competence determine benefit?
An intra-aortic balloon inflates during diastole after aortic valve closure and deflates before ventricular ejection. Diastolic inflation augments aortic pressure; timely deflation reduces ventricular ejection load. Early inflation can oppose ejection and increase afterload, so a large augmented peak alone does not establish correct assistance. Significant aortic insufficiency is a manufacturer-listed contraindication: diastolic augmentation can increase regurgitant flow into the left ventricle and worsen volume loading.
Apply it
If the inflation marker precedes aortic valve closure, communicate possible early inflation and assess perfusion while timing is corrected. Before placement, highlight severe aortic regurgitation as a contraindication even when output is low.
Common pitfall: Neither low output nor a prominent augmented pressure proves that balloon support is suitable or correctly timed. Assess waveform timing, valve pathology, and the patient's perfusion response.
35.How should postoperative drain findings guide escalation and removal decisions?
Trend drainage volume, character, and air leakage with hemodynamics. Drains remove blood, fluid, and air; retained material can cause tamponade, hemothorax, or pneumothorax. Instability or tamponade warrants surgical re-exploration assessment. No universal output threshold or removal time is established by the blood-management guideline.
Apply it
An abrupt output decrease with rising venous pressure and falling cardiac output requires urgent assessment for retained blood, not drain removal. Persistent air leakage also informs the removal decision.
Common pitfall: A low collection volume does not establish effective drainage. Premature removal can leave retained fluid; prolonged drainage also carries costs.
2024%20EACTS%20Guideline%20on%20Patient%20Blood%20Management.pdf · 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
36.How should respiratory deterioration after extubation guide support?
After extubation, assess respiratory rate and effort, oxygen requirement, alertness, and ability to clear secretions and protect the airway. ERS/ATS conditionally supports NIV for selected postoperative acute respiratory failure after assessment of surgical causes. A cooperative patient with preserved airway protection may receive a closely monitored NIV trial; worsening consciousness, inability to protect the airway, or progressive respiratory failure requires prompt invasive-airway assessment. A better saturation alone does not establish adequate ventilation or reduced work of breathing. [ERS/ATS NIV guideline](https://www.thoracic.org/statements/resources/cc/niv-guidelines.pdf).
Apply it
An alert patient develops hypoxemia and increased respiratory effort after cardiac surgery. Assess reversible causes and suitability for NIV. If effort and mental status worsen during support, prepare for reintubation instead of repeatedly extending an ineffective trial.
Common pitfall: Postoperative NIV is conditional on patient selection and close reassessment. It must not delay intubation when airway protection or ventilation is failing.
37.How should venous thromboembolism prevention change as postoperative bleeding resolves?
Immobility and patient factors such as prior VTE increase postoperative thrombosis risk. The cardiac surgery blood-management guideline supports pharmacologic prophylaxis with UFH or LMWH as soon as it is safe after surgery, continuing until full mobilization. Assess active bleeding and hemostatic stability before initiation, renal function when selecting or adjusting LMWH, and any HIT concern before using either heparin preparation. Early mobility complements the prescribed prophylaxis plan. A temporary bleeding-related delay should trigger reassessment as hemostasis improves rather than indefinite omission.
Apply it
A patient initially had active mediastinal bleeding, so pharmacologic prophylaxis was deferred. Bleeding has resolved, but the patient remains largely immobile. Reassess the prophylaxis plan now, including renal function and platelet trajectory, instead of automatically carrying the original hold forward.
Common pitfall: Drain presence alone does not quantify current bleeding risk. Conversely, a fixed postoperative time does not establish safety while hemorrhage continues; suspected HIT requires a non-heparin pathway.
2024%20EACTS%20Guideline%20on%20Patient%20Blood%20Management.pdf · ASH Diagnosis and Management of Heparin-Induced Thrombocytopenia · SCCM 2025 Focused Update to PADIS Guidelines
38.When can a restrictive red-cell threshold be considered after cardiac surgery?
The 2023 AABB guideline allows clinicians to choose a hemoglobin threshold of 7.5 g/dL for hemodynamically stable adults undergoing cardiac surgery. This is a restrictive transfusion strategy, not an automatic order or a threshold for every postoperative situation. Active bleeding, instability, and other clinical concerns require separate assessment. Red cells primarily improve oxygen-carrying capacity; they should not be selected to correct an isolated platelet or coagulation-factor deficit.
Apply it
A stable postoperative patient has hemoglobin 8.1 g/dL, no active bleeding, and reassuring perfusion. The cardiac surgery restrictive threshold does not support automatic transfusion solely to restore hemoglobin to a traditional higher target.
Common pitfall: Do not apply a stable-patient threshold mechanically during ongoing hemorrhage or instability. A threshold supports a decision framework; it does not replace clinical assessment.
Red Blood Cell Transfusion: 2023 AABB International Guidelines
39.How do plasma and platelets address different hemostatic deficits?
Plasma supplies coagulation factors, whereas platelet components provide platelets that contribute to primary hemostasis and clot strength. Neither product is interchangeable with red cells, whose main purpose is oxygen carriage. In a bleeding cardiac surgery patient, selection should follow the demonstrated deficit and clinical context. A prolonged coagulation time and a low platelet count may indicate different or simultaneous needs, while additional evaluation may identify fibrinogen deficiency or a surgical source.
Apply it
A patient has active diffuse bleeding, a substantially prolonged coagulation time, and severe thrombocytopenia. Recognize that more than one hemostatic deficit may be present rather than expecting a red-cell transfusion to correct both abnormalities.
Common pitfall: Do not assume that all blood components improve every aspect of coagulation. Match the component to the deficit and avoid treating laboratory abnormalities without clinical context.
2024 EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery
40.When does fibrinogen replacement address a specific bleeding mechanism?
Fibrinogen supplies the substrate for fibrin formation and contributes substantially to clot firmness. A bleeding patient with demonstrated fibrinogen deficiency requires a different treatment discussion from one with isolated thrombocytopenia or residual heparin effect. Cryoprecipitate or fibrinogen concentrate may provide replacement according to the applicable clinical protocol and product availability. Interpret fibrinogen measurements and functional clot contribution together when available, and reassess because multiple deficits can coexist after cardiac surgery.
Apply it
Active bleeding persists with a low measured fibrinogen concentration and reduced fibrin-based clot contribution, while platelet count and heparin assessment are reassuring. Identify fibrinogen replacement as the targeted treatment discussion rather than adding red cells for hemostasis.
Common pitfall: Weak overall clot strength does not uniquely identify fibrinogen deficiency. Platelet abnormalities can produce a similar appearance, so use discriminating results before selecting treatment.
2024 EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery · Haemonetics TEG 5000 Hemostasis Analyzer System Brochure
41.Why is early aspirin resumption considered after CABG?
Aspirin inhibits platelet activation and supports prevention of early graft thrombosis after CABG. The cardiac surgery blood-management guideline discusses restarting aspirin within 24 hours when safe, with evidence favoring initiation within six hours. The timing must be reconciled with surgical hemostasis rather than treated as unconditional. A useful nursing assessment identifies whether aspirin has been prescribed, whether bleeding remains active, and whether a documented reason exists for delaying the intended postoperative antiplatelet plan.
Apply it
Four hours after CABG, a patient has stable hemostasis and an ordered aspirin dose. Recognize the graft-protection rationale and assess for contraindications rather than routinely withholding antiplatelet treatment merely because surgery occurred earlier that day.
Common pitfall: Early does not mean regardless of bleeding. Conversely, the general presence of postoperative drains is not by itself evidence that an intended aspirin dose must be delayed.
2024 EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery
42.How does suspected HIT change anticoagulant management?
ASH recommends stopping heparin and starting therapeutic-intensity non-heparin anticoagulation for high-probability suspected HIT. With intermediate probability, high bleeding risk, and no separate indication for therapeutic anticoagulation, prophylactic intensity can be appropriate pending results; otherwise therapeutic intensity is used. Options include argatroban, bivalirudin, danaparoid, fondaparinux, and selected direct oral anticoagulants. Short-acting intravenous argatroban or bivalirudin may suit critical illness or possible urgent procedures; organ function affects selection and dosing. Avoid starting a vitamin K antagonist before platelet recovery, usually ≥150,000/µL: premature treatment can cause skin necrosis, venous limb gangrene, and other serious thrombosis.
Apply it
A patient has a high-probability platelet trajectory and new thrombosis during heparin exposure. Anticipate therapeutic-intensity non-heparin treatment, such as prescribed bivalirudin or argatroban, while testing proceeds. A different patient with intermediate probability, major bleeding risk, and no other therapeutic indication may initially receive prophylactic intensity pending results.
Common pitfall: LMWH is not a safe substitute for heparin in suspected HIT. Direct oral anticoagulants are options only in suitable HIT patients; they remain contraindicated for mechanical prosthetic valves.
ASH Diagnosis and Management of Heparin-Induced Thrombocytopenia · 2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 3 - American College of Cardiology
43.How is a lung-protective tidal volume calculated for ARDS?
The ARDS ventilation guideline recommends tidal volumes of 4–8 mL/kg predicted body weight, with limitation of plateau pressure to below 30 cm H2O. Predicted body weight reflects expected lung size rather than current body mass. A commonly used starting calculation is 6 mL/kg predicted body weight, followed by adjustment to the patient's mechanics and clinical condition. Actual weight can substantially overestimate a protective volume in a patient with obesity or fluid accumulation.
Apply it
A patient has predicted body weight of 60 kg and actual weight of 95 kg. A 6 mL/kg starting tidal volume is 360 mL, not 570 mL; evaluate plateau pressure and gas exchange after implementation.
Common pitfall: Do not substitute actual body weight for predicted body weight. Postoperative edema and obesity increase body mass without proportionally increasing the volume of lung available for safe ventilation.
ATS/ESICM/SCCM Mechanical Ventilation in Adult Patients With ARDS — 2017
44.When is prolonged prone positioning supported for ARDS?
The 2017 ARDS guideline recommends prone positioning for more than 12 hours per day in adults with severe ARDS. Proning changes the distribution of ventilation and mechanical stress and is used as part of a lung-protective strategy. In a recent cardiac surgery patient, eligibility requires explicit assessment of operative wounds, drains, vascular access, and hemodynamic tolerance. The ARDS recommendation supports consideration in the appropriate severity group; it does not make every postoperative patient automatically suitable.
Apply it
A patient has severe ARDS despite a protective ventilation strategy. Discuss prone positioning with the multidisciplinary team while evaluating fresh surgical wounds, pacing wires, drains, and circulatory stability before organizing a controlled turn.
Common pitfall: Do not treat prone positioning as merely a brief oxygenation maneuver. The supported strategy uses prolonged sessions and requires assessment of surgical and device-related constraints.
ATS/ESICM/SCCM Mechanical Ventilation in Adult Patients With ARDS — 2017
45.How should pain be assessed when a patient cannot self-report?
Reliable self-report remains preferred; intubation alone does not prevent communication by pointing or other methods. When self-report is unavailable and behaviors are observable, use the Critical-Care Pain Observation Tool (CPOT). Its four domains are facial expression, body movements, muscle tension, and ventilator compliance for intubated patients or vocalization for extubated patients. Each domain scores 0–2, producing a total of 0–8. Observe at rest and during care, then repeat after analgesia. CPOT measures pain-related behaviors rather than a patient's numerical pain intensity. Heart rate and blood pressure changes can trigger further assessment but cannot independently measure pain.
Apply it
During repositioning, a noncommunicating intubated patient has grimacing scored 2, protective movement 1, tense muscles 1, and coughing while tolerating ventilation 1: CPOT totals 5. Provide prescribed analgesia and reassess after its expected onset, including during comparable care. A relaxed face 0, normal movement 0, persistent mild muscle tension 1, and ventilator tolerance 0 produce a total of 1, supporting reduced pain-related behavior. Also assess respiratory status, blood pressure, and sedation for treatment adverse effects.
Common pitfall: PADIS supports behavioral tools when behaviors are observable. Neuromuscular blockade can abolish movement, facial responses, and muscle tension; absent movement during paralysis cannot establish absence of pain or justify recording a reassuring behavioral score. Maintain prescribed analgesia for expected painful conditions and procedures. Sedation and paralysis provide no substitute for analgesia.
46.How should postoperative sedation be matched to a defined clinical goal?
Compare the observed Richmond Agitation-Sedation Scale (RASS) score with an explicitly prescribed target. Assess spontaneous behavior, then response to voice and, if needed, physical stimulation. Representative anchors are 0, alert and calm; −1, drowsy with eye contact to voice lasting more than 10 seconds; −2, brief eye contact lasting less than 10 seconds; −3, movement or eye opening to voice without eye contact; −4, response only to physical stimulation; and −5, no response to voice or physical stimulation. PADIS generally favors light sedation when appropriate. Its 2025 update conditionally suggests dexmedetomidine over propofol for mechanically ventilated adults when light sedation or delirium reduction is a highest priority.
Apply it
A stable ventilated patient has a prescribed RASS target of −1 to 0 but opens the eyes to voice without making eye contact: actual RASS is −3, deeper than prescribed. Reassess pain, sedative and opioid exposure, ventilation, hemodynamics, and any continuing indication for deeper sedation. If none exists, reduce the sedative according to the prescribed titration protocol, monitor closely, and repeat RASS after the adjustment takes effect. Persistent unexpected reduced responsiveness warrants evaluation beyond medication titration.
Common pitfall: The example target is patient specific, not universal. Some clinical circumstances require deeper sedation. Drug choice must account for physiology and treatment goals; the conditional dexmedetomidine preference does not require switching every postoperative patient. A sedation score measures arousal and agitation, not analgesic adequacy or delirium.
SCCM 2018 PADIS Guidelines · SCCM 2025 Focused Update to PADIS Guidelines · Monitoring Delirium in the ICU
47.How can nonpharmacologic care reduce delirium-related risk?
PADIS supports a multicomponent nonpharmacologic approach that addresses modifiable delirium risks and supports cognition, sleep, mobility, hearing, and vision. These measures help reduce avoidable disorientation and inactivity without assuming that a sedative or antipsychotic resolves the underlying syndrome. Interventions should be adapted to the patient's abilities and stability. Regular validated assessment remains necessary because prevention measures do not exclude delirium and a quiet patient may still have substantial inattention.
Apply it
A postoperative patient is awake but disoriented, without glasses or hearing aids and with repeated overnight interruptions. Restore sensory aids, provide orientation and sleep support, review medications, and continue validated delirium assessment.
Common pitfall: Do not interpret a calm appearance as successful delirium prevention. Hypoactive delirium can persist, and medication-induced quietness may obscure attention and cognition further.
48.How should intravenous insulin be monitored in critically ill adults?
The SCCM guideline supports treatment protocols that minimize hypoglycemia and advises against intensive adult targets of 80–139 mg/dL compared with a higher 140–200 mg/dL range. These comparison ranges do not replace an institution's chosen protocol. During glycemic instability on intravenous insulin, frequent monitoring at intervals of one hour or less is supported. Trends, nutritional interruptions, and changes in clinical condition should inform protocol-based adjustment rather than reliance on a single apparently acceptable glucose value.
Apply it
An insulin infusion has recently been adjusted and glucose is falling quickly. Continue frequent protocol-directed checks and reassess nutrition instead of extending the monitoring interval simply because the latest value entered the desired range.
Common pitfall: Do not present the guideline's comparison range as a universal individual target. Avoid intensive control and tailor safe implementation through a validated insulin protocol.
SCCM Guidelines on Glycemic Control for Critically Ill Children and Adults — 2024
49.When does AKI require urgent kidney replacement therapy?
KDIGO recommends emergency kidney replacement therapy when life-threatening fluid, electrolyte, or acid-base disturbances exist. Examples include refractory dangerous hyperkalemia, severe acid-base derangement, or fluid overload compromising respiratory function. The broader clinical context and trends matter more than an isolated blood urea nitrogen or creatinine threshold. A patient may need urgent treatment despite moderate creatinine elevation, while a stable patient with a high value may require a different timing assessment.
Apply it
A patient with AKI has refractory hyperkalemia and worsening pulmonary edema despite appropriate medical measures. Identify the immediately dangerous complications as the reason for urgent renal-support evaluation rather than waiting for creatinine to reach a predetermined number.
Common pitfall: Do not reduce initiation to a single laboratory cutoff. The urgency arises from complications, their trajectory, and whether available medical treatment can control them.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
50.Why may continuous kidney replacement therapy suit an unstable patient?
Continuous kidney replacement therapy provides gradual solute and fluid removal over time rather than concentrating treatment into a short intermittent session. KDIGO suggests continuous therapy rather than standard intermittent treatment for hemodynamically unstable patients. This supports a modality choice based on circulatory tolerance, not an assertion that continuous therapy universally improves survival. Ongoing assessment includes delivered treatment, fluid balance, electrolytes, anticoagulation considerations, and the patient's changing need for support.
Apply it
A vasopressor-dependent patient requires renal support and cannot tolerate rapid volume shifts. Recognize why a continuous modality may be selected, then evaluate the prescribed net fluid removal against blood pressure, perfusion, and cumulative balance.
Common pitfall: Continuous therapy is not automatically superior for every patient with AKI. Hemodynamic tolerance and treatment goals guide selection, and the appropriate modality can change during recovery.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
51.How should early mobility be adapted after cardiac surgery?
The 2025 PADIS focused update supports enhanced mobilization or rehabilitation over usual care, with conditional recommendations reflecting the evidence. Mobility should progress according to physiologic tolerance and the patient's surgical and device constraints. An intervention can begin below the level of walking and advance as stability permits. Assess symptoms, perfusion, oxygenation, lines, and recovery after activity; neither a fixed postoperative clock nor the presence of an invasive device alone determines the appropriate activity level.
Apply it
An awake postoperative patient is considered for sitting at the bedside. Review hemodynamic stability and secure drains and pacing connections, then monitor tolerance during progression instead of treating ambulation as the only meaningful form of early mobility.
Common pitfall: Enhanced mobilization does not mean maximal activity regardless of stability. Choose a tolerable level, reassess response, and progress rather than applying a uniform activity target.
52.Why is correction of hypothermia part of postoperative hemostatic care?
Hypothermia impairs hemostatic function and can contribute to bleeding after cardiac surgery. Temperature management therefore belongs alongside evaluation of platelet, fibrinogen, coagulation-factor, and surgical contributors. Rewarming addresses a physiologic impediment to clot formation; it does not replace component treatment when a demonstrated deficit exists or surgical intervention when a focal source persists. Follow measured temperature and clinical response while avoiding the assumption that a coagulation result captures every temperature-related limitation.
Apply it
A bleeding patient remains hypothermic after bypass. Continue prescribed controlled rewarming while evaluating coagulation deficits and surgical bleeding, rather than expecting repeated blood components alone to correct hemostasis in the persistently cold patient.
Common pitfall: Do not attribute all bleeding to hypothermia or postpone urgent surgical assessment until normothermia. Temperature correction is one component of a simultaneous hemostatic strategy.
2024 EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery
Monitoring and Diagnostics13%
53.How is cardiac index calculated and interpreted?
Cardiac index is cardiac output divided by body surface area, expressed in L/min/m². Indexing allows comparison of flow relative to body size rather than using the same absolute output for every adult. The calculation does not establish the cause of a low value or prove adequate tissue oxygenation. Interpret it with hemoglobin, oxygenation, filling pressures, vascular resistance, and perfusion trends to identify whether measured flow is meeting the patient's current needs.
Apply it
A patient's cardiac output is 4.2 L/min and body surface area is 2.0 m². Cardiac index is 2.1 L/min/m². Relate that indexed flow to perfusion findings rather than judging 4.2 L/min in isolation.
Common pitfall: Do not multiply output by body surface area. A correct cardiac-index calculation also does not explain whether low flow reflects preload, contractility, rhythm, or obstruction.
Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values
54.How is systemic vascular resistance calculated?
Systemic vascular resistance is calculated as 80 × (mean arterial pressure minus central venous pressure) divided by cardiac output, using conventional units to obtain dyn·s·cm⁻⁵. The pressure difference represents the systemic driving gradient, and division by flow estimates resistance. Because cardiac output is in the denominator, an inaccurate output measurement distorts the result. Use resistance to interpret the pressure-flow relationship, not as an independent diagnosis detached from volume status, pump function, and perfusion.
Apply it
With mean arterial pressure 70 mm Hg, central venous pressure 10 mm Hg, and cardiac output 5 L/min, resistance is 80 × 60 ÷ 5 = 960 dyn·s·cm⁻⁵. Recheck the input measurements before using the result clinically.
Common pitfall: Do not omit central venous pressure or confuse cardiac output with cardiac index. Each produces a different calculation and may misclassify the hemodynamic pattern.
Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values
55.How do hemoglobin, saturation, and PaO2 contribute to arterial oxygen content?
Arterial oxygen content combines oxygen bound to hemoglobin with the much smaller dissolved component. The usual equation is approximately 1.34 × hemoglobin × arterial saturation, plus 0.003 × PaO2, with saturation expressed as a fraction and content in mL O2/dL. This explains why a high PaO2 cannot compensate fully for major anemia. Oxygen delivery then depends on both arterial content and cardiac output, so content and flow require separate assessment.
Apply it
Using hemoglobin 10 g/dL, saturation 1.00, and PaO2 100 mm Hg, estimated arterial oxygen content is 13.4 + 0.3 = 13.7 mL O2/dL. Most oxygen is carried by hemoglobin, not dissolved in plasma.
Common pitfall: Do not insert saturation as 100 instead of 1.00. Also avoid treating PaO2, saturation, oxygen content, and oxygen delivery as interchangeable measurements.
Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values
56.How is oxygen extraction calculated and used?
The oxygen extraction ratio is the difference between arterial and mixed venous oxygen content divided by arterial content. It describes the proportion of delivered oxygen removed by tissues. Increased extraction can accompany reduced delivery or increased demand, but its interpretation depends on the clinical context and sampling accuracy. Mixed venous saturation alone does not identify whether a change arose from cardiac output, hemoglobin, arterial oxygenation, metabolic demand, or impaired tissue extraction.
Apply it
Arterial oxygen content is 20 mL O2/dL and mixed venous content is 15 mL O2/dL. Extraction is (20 − 15) ÷ 20 = 25%. Interpret a subsequent increase with the patient's flow and metabolic demands.
Common pitfall: Do not divide by mixed venous content or assume every venous-saturation change is caused by cardiac output. Delivery and consumption both influence the result.
Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values
57.How should an arterial blood gas be interpreted systematically?
Begin with pH to identify acidemia or alkalemia, then compare PaCO2 and bicarbonate with the direction of the pH change. Increased PaCO2 acidifies, while increased bicarbonate alkalinizes. Determine which component explains the primary disturbance and whether the other moves in a compensatory or additional pathologic direction. Evaluate oxygenation separately. A nearly normal pH can conceal important opposing abnormalities, so do not stop interpretation after deciding that pH is inside a reference interval.
Apply it
A gas shows pH 7.49, PaCO2 30 mm Hg, and bicarbonate 22 mEq/L. The alkalemia aligns with reduced carbon dioxide, supporting a primary respiratory alkalosis pattern; then relate it to the patient's ventilation and clinical circumstances.
Common pitfall: Do not call every abnormal bicarbonate value a primary metabolic disorder. Its direction may reflect compensation, and oxygenation is a separate interpretive task.
58.What does whole-blood viscoelastic testing add to plasma coagulation tests?
Viscoelastic testing evaluates the evolving mechanical behavior of a whole-blood clot, including initiation, development, strength, and breakdown. Plasma clotting-time tests answer narrower questions about coagulation pathways and do not directly describe the complete whole-blood clot. A weak clot can reflect more than one mechanism, so interpretation requires the appropriate assay channels and supporting laboratory data. Use the pattern to support targeted assessment rather than equating one abnormal tracing feature with one universally correct component.
Apply it
A patient has ongoing bleeding and a weak overall viscoelastic clot despite only modest changes in plasma clotting times. Examine platelet and fibrinogen contributions before choosing treatment, rather than assuming the plasma results exclude important hemostatic dysfunction.
Common pitfall: Overall clot strength is not a platelet count. Without discriminating tests, a weak tracing cannot reliably separate platelet dysfunction from inadequate fibrin contribution.
Haemonetics TEG 5000 Hemostasis Analyzer System Brochure · 2024 EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery
59.How does echocardiography clarify suspected postoperative tamponade?
Echocardiography evaluates the location of pericardial material and its effects on cardiac chambers and filling. The relevant question is not simply whether an effusion exists but whether it contributes to hemodynamic compromise. Postoperative collections may be loculated, and a limited examination may not show all clinically important material. Interpret images with the patient's deterioration and obtain further expert assessment when findings and physiology disagree rather than dismissing persistent concern after an incomplete view.
Apply it
A patient has progressive low-output findings, but an initial limited study shows no large circumferential effusion. Maintain concern for localized postoperative compression and obtain urgent expert reassessment instead of treating the limited image as definitive exclusion.
Common pitfall: Effusion size alone does not determine hemodynamic significance. A localized postoperative collection may matter greatly, while a visible collection without compression may have another significance.
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
60.Why is plateau pressure more informative than peak pressure for ARDS lung protection?
Peak inspiratory pressure includes pressure required to overcome airway resistance as well as the elastic load of the respiratory system. Plateau pressure, measured during an appropriate inspiratory hold without flow, better reflects the static elastic pressure associated with the delivered volume. The ARDS guideline recommends limiting plateau pressure below 30 cm H2O. A high peak pressure alone does not establish excessive alveolar distending pressure, but it still requires investigation of the pressure pattern and airway.
Apply it
A ventilated patient develops a higher peak pressure while plateau pressure remains unchanged. Investigate increased airway resistance or circuit factors rather than assuming that static lung distending pressure has risen by the same amount.
Common pitfall: Do not substitute peak pressure for a properly obtained plateau measurement. Patient effort, ongoing flow, and measurement technique can also make a displayed plateau unreliable.
ATS/ESICM/SCCM Mechanical Ventilation in Adult Patients With ARDS — 2017
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Prioritize Therapeutic Interventions and Complications while retaining regular practice in Procedures and Monitoring and Diagnostics.
- For postoperative hypotension, connect pressure with flow, resistance, filling, bleeding, rhythm, and possible mechanical obstruction.
- Distinguish platelet, fibrinogen, coagulation-factor, hemoglobin, and surgical problems before selecting blood-management interventions.
- Practise pacing output versus sensitivity, IABP timing, predicted-body-weight ventilation, and oxygen-delivery calculations.
- Rehearse postoperative tachyarrhythmia and arrest responses, drain-related deterioration, mechanical-support bleeding and thrombosis decisions, and post-TAVR surveillance criteria.
- Rehearse recognition of new lower-limb deficits after aortic repair, post-extubation escalation, and reassessment of thrombosis prophylaxis.
- Use the full official outline to study additional procedures, broader mechanical-support management, stroke, psychosocial complications, and prevention protocols.
- Match the study plan to the examination date because the revised blueprint begins November 19, 2026.
A practical preparation plan
1. Anchor study to the applicable outline
Confirm the examination date, select the corresponding official test plan, and mark every listed topic. Use these concepts as a focused starting point while identifying outline topics requiring additional study.
2. Build postoperative differential patterns
Compare paired cases: low preload versus congestive pump failure, tamponade versus ongoing external blood loss, TACO versus TRALI, and ordinary postoperative thrombocytopenia versus a compatible HIT pattern. Identify the finding that changes management.
3. Practise interventions with explicit response measures
For each treatment, state the intended physiologic change and how to assess it. Examples include output after fluid, perfusion after pacing, plateau pressure after ventilator adjustment, and bleeding response after targeted hemostatic therapy.
4. Calculate and explain
Work cardiac index, vascular resistance, oxygen content, extraction, weight-based urine output, and predicted-body-weight tidal volume without viewing the worked examples. Explain what each result establishes and what it cannot establish.
5. Use the drills to direct further learning
Answer the 20 questions before reading explanations. Review why every alternative is less appropriate, record the missed discriminating cue, and revisit related official-outline topics. Use flashcards for spaced active recall rather than as a measure of passing probability.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- CSC Certification — AACN
- CSC Exam Handbook — August 2026
- Revised CMC and CSC Exams Launch Nov. 19, 2026
- CSC Test Plan — Effective November 19, 2026
- Coronary Artery Bypass Grafting — What to Expect During Surgery
- ACC Decision Pathway on Conduction Disturbances in TAVR: Key Points
- 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
- Acute Kidney Injury and Acute Kidney Disease — KDIGO
- KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
- ASH Diagnosis and Management of Heparin-Induced Thrombocytopenia
- Choosing Wisely — American Society of Hematology
- NHSN Hemovigilance Module Protocol v3.0 — January 2026
- Protamine Sulfate Injection — Prescribing Information
- SCCM 2018 PADIS Guidelines
- SCCM 2025 Focused Update to PADIS Guidelines
- 2024 EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery
- SCCM Guidelines on Glycemic Control for Critically Ill Children and Adults — 2024
- Medtronic Model 5392 Temporary Pacemaker Reference Guide
- Arrow AC3 Safety Information — Teleflex
- ATS/ESICM/SCCM Mechanical Ventilation in Adult Patients With ARDS — 2017
- Edwards Clinical Education — Normal Haemodynamic Parameters and Laboratory Values
- OpenStax Fundamentals of Nursing — Acid-Base Balances
- Haemonetics TEG 5000 Hemostasis Analyzer System Brochure
- Red Blood Cell Transfusion: 2023 AABB International Guidelines
- 2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 3 - American College of Cardiology
- 2024%20EACTS%20Guideline%20on%20Patient%20Blood%20Management.pdf
- Visual-abstract-final.pdf
- 2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 1 - American College of Cardiology
- Perioperative Management of Antithrombotic Therapy | Pulmonary Vascular - American College of Chest Physicians
- watermark-ash_vte_hit_pocketguide.pdf
- 2024-EACTS-EACTAIC-EBCP-CPB-Guidelines.pdf
- niv-guidelines.pdf
- ash_vte_hit_pocketguide.pdf
- Monitoring Delirium in the ICU
- Normal%20Hemodynamic%20Parameters%20and%20Lab%20Values%20-EU%20Master%20(1).pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.